PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31365252-3	2019	Herein, we report the discovery of BI-4916, a prodrug of the co-factor nicotinamide adenine dinucleotide (NADH/NAD+)-competitive PHGDH inhibitor BI-4924, which has shown high selectivity against the majority of other dehydrogenase targets.	BI-4916	35-42	phosphoglycerate dehydrogenase	Homo sapiens	129-134	
35577770-7	2022	We observe that increased serine de novo synthesis (SSP) supports mitochondrial serine catabolism and inhibition of SSP using the competitive PHGDH-inhibitor BI-4916 reduces cancer cell migration.	BI-4916	158-165	phosphoglycerate dehydrogenase	Homo sapiens	142-147